Tom Glocer is a Co-Founder and Executive Chairman of BlueVoyant. Tom has been an active investor via his family office since he stepped down as CEO of Thomson Reuters in December 2011. Prior to April 2008, Tom was CEO of Reuters, where he held a number of key leadership positions.
Tom previously practiced law at Davis Polk & Wardwell in New York, Paris, and Tokyo. He is the Lead Director of the Morgan Stanley Board and a director of Merck & Co., Inc., Publicis Groupe, K2 Intelligence, Inc., and the Atlantic Council. He is the Executive Chairman of Capitolis, a trustee of the Cleveland Clinic, and serves on The International Advisory Group of Linklaters LLP.